Neurocrine Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Net Income	348.3	341.3	249.7	154.5	89.6	407.3	Upgrade
Depreciation & Amortization	28.5	27.1	21.3	15.6	10.9	8.6	Upgrade
Stock-Based Compensation	213.5	195.5	194.3	173.1	134.2	100	Upgrade
Other Adjustments	-30.1	50.7	-103.6	63.6	5.1	-249.5	Upgrade
Change in Receivables	-127.5	-39.8	-89.3	-162.2	-28.4	-30.5	Upgrade
Changes in Inventories	-14.5	-19.1	5.4	-2.6	-2.5	-10.7	Upgrade
Changes in Accounts Payable	135	29	64.3	114.6	56.8	26.9	Upgrade
Changes in Other Operating Activities	42.9	10.7	47.8	-17.2	-9.2	-23.6	Upgrade
Operating Cash Flow	567.3	595.4	389.9	339.4	256.5	228.5	Upgrade
Operating Cash Flow Growth	6.96%	52.71%	14.88%	32.32%	12.25%	55.44%	Upgrade
Capital Expenditures	-38.6	-38.2	-28.3	-16.5	-23.4	-10.9	Upgrade
Purchases of Investments	-1,133	-1,056	-1,380	-628.9	-804.7	-735.5	Upgrade
Proceeds from Sale of Investments	1,113	967.5	972.4	511	697.9	750.5	Upgrade
Payments for Business Acquisitions	-	-	-31.3	-42.7	-	-	Upgrade
Investing Cash Flow	-58.4	-126.8	-467.1	-177.1	-130.2	4.1	Upgrade
Long-Term Debt Repaid	-	-308.8	-	-279	-0.1	-186.9	Upgrade
Net Long-Term Debt Issued (Repaid)	-	-308.8	-	-279	-0.1	-186.9	Upgrade
Issuance of Common Stock	82.9	122.1	65.3	44.7	27.5	29.1	Upgrade
Repurchase of Common Stock	-	-300	-	-	-	-	Upgrade
Net Common Stock Issued (Repurchased)	82.9	-177.9	65.3	44.7	27.5	29.1	Upgrade
Financing Cash Flow	-384.8	-486.7	65.3	-234.3	27.4	-157.8	Upgrade
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-	0.3	-1.3	-	-	Upgrade
Net Cash Flow	124.3	-18.1	-11.6	-73.3	153.7	74.8	Upgrade
Beginning Cash & Cash Equivalents	147.7	259.1	270.7	344	190.3	115.5	Upgrade
Ending Cash & Cash Equivalents	272	241	259.1	270.7	344	190.3	Upgrade
Free Cash Flow	528.7	557.2	361.6	322.9	233.1	217.6	Upgrade
Free Cash Flow Growth	-5.12%	54.09%	11.98%	38.52%	7.12%	64.48%	Upgrade
FCF Margin	21.06%	23.66%	19.16%	21.69%	20.56%	20.81%	Upgrade
Free Cash Flow Per Share	5.15	5.37	3.58	3.26	2.38	2.22	Upgrade
Levered Free Cash Flow	501.6	42	360.2	-30.6	122.1	210.7	Upgrade
Unlevered Free Cash Flow	496.54	422.19	293.33	262.12	120.08	457.26	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.